[FDA Consumer Magazine]


VOL. 31 NO. 4[space]MAY-JUNE 1997


Features

Label Literacy for OTC Drugs
If you can't understand, or even find, all the precautions and instructions on a bottle of cough syrup or pain reliever, FDA's proposed medicine facts panel may be the answer.

CFC-Free Medication for an Ailing Ozone Layer
Protect the environment or provide life-saving drugs? FDA proposes to solve that dilemma with the phaseout of chlorofluorocarbon-containing medical products, but not until safe and effective alternatives are available.

Lights, Camera, Telemedicine
Putting television and medicine together used to mean nothing more than a weekly dose of Dr. Kildare. But video cameras, cable hookups, and computers can now help patients and doctors get medical advice from specialists all over the country.

Today's Special: Nutrition Information
The time has come for your favorite restaurant to spill the high-fiber beans. FDA now requires restaurants to give customers nutrition information about menu items with nutrition or health claims.

Reasons for Brain Tumor Increase Not Black and White
In the United States, the number of brain tumors has doubled in the past 10 years. But early diagnosis and the right treatment can improve the chances of recovery.

Diabetes Demands a Triad of Treatments
Diabetics need to fight their disease with every weapon they have: diet, exercise, drugs, and--for many--daily insulin injections. Now a new class of drugs just approved by FDA may help some reduce or eliminate their need for insulin injections.


Departments

Updates
The latest information on FDA-related issues, gathered from FDA Press Releases, Talk Papers, and other sources.

Notebook
A potpourri of items of interest gathered from the Federal Register and other sources.

Investigators' Reports
Selected cases illustrating regulatory and administrative actions--such as inspections, recalls, seizures, and court proceedings--by FDA's regional and district offices across the country

Summaries of Court Actions
Cases involving seizure, criminal and injunction proceedings.


[FDA Home Page] [How to Subscribe] [Back Issues]